Startups
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
Overview
Location
United States, Massachusetts, Boston
Employees
11-50
Founded date
2017
Investors 3
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 18, 2024 | Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development | High performance two-plasmid production system achieves E12 vg/mL unconcentrated titers AI-driven design tools to improve expression precision, efficacy, and manufacturability Boston, Massachusetts, 18 Sep 2024: Asimov, the synthetic biolog... |
| Apr 29, 2024 | Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service | Stable lentiviral (LV) cell line development service achieves unconcentrated titers >1E9 TU/mL for therapeutic transgenes. Fully stable cell lines have all viral genes and transgene stably integrated, enabling biomanufacturing scalabilit... |
| Jan 29, 2024 | Asimov launches LV Edge Packaging System to optimize lentivirus production | Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of their LV Edge Packaging System, which improves the cost efficiency and reduces the supply chain risk of lentiviral pro... |
| Mar 27, 2023 | Meet The Three Berkeley Dropouts Empowering Biotechs With Low-Code Cloud-Based Biocomputing | LatchBio founders: Alfredo Andere, Kenny Workman, and Kyle Giffin.LatchBio |
| Jan 5, 2023 | Drug Manufacturing Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200 Million To Fix It. | The four Asimov co-founders, from left to right: Doug Densmore, Alec Nielsen, Raja Srinivas and ... [+] Chris Voigt.Asimov. |
| Nov 7, 2022 | Class of 2023 | From day one, Contrary’s mission has been to identify the brightest, scrappiest, and most talented builders in the world, and support them for life. Alongside many other initiatives, we do this with our community - and for the past 6 years,... |
| Jan 10, 2022 | New Year, New Fund, New Opportunities in Bio + Health | 2021 saw higher than ever funding of startups, continued maturation of the tech-enabled bio and healthcare landscape, and new platforms and business models that propelled growing levels of adoption and scale amongst both upstarts and tradit... |
| Asimov | “Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.” |
Reviews 0
FAQ about Asimov
When was Asimov founded?
Asimov was founded in 2017.
What has the press written about Asimov?
Parsers VC has collected 9 articles mentioning Asimov, among them “Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development” (Sep 18, 2024) and “Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service” (Apr 29, 2024).
Is Asimov still active?
Yes, Asimov is active; its latest activity on Parsers VC dates from May 20, 2025.